Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

ACIP logo The Advisory Committee on Immunization Practices (ACIP) is a group of medical and public health experts that develop recommendations on use of vaccines in the civilian population of the United States…


Register for upcoming February ACIP meeting

February 21-22, 2018

Deadline for registration:
Non-US Citizens: January 24, 2018
US Citizens: February 5, 2018

Registration is NOT required to watch the live meeting webcast or to listen via telephone.

Public Comment Instructions [1 page]

ACIP Recommendations

General Committee-related Information

  • Charter
    Defines ACIP's purpose, authority, and function; its structure, meetings, and compensation; plus costs, reports, and termination.
  • Members
    Membership roster, including chair, executive secretary, voting members, ex officio members, and liaison representatives.
  • Articles
    Journal articles about the ACIP.


ACIP Flyer

ACIP brochure This ACIP flyer [2 pages] answers questions such as what does the ACIP consider in the vaccine recommendation process, including recommended ages for administration of various vaccines to children?

Updated Guidance for Yellow Fever Vaccine

To avoid a lapse in yellow fever vaccine availability in the United States, the manufacturer, Sanofi Pasteur, has received approval from FDA to import Stamaril yellow fever vaccine. Stamaril is produced by Sanofi Pasteur in France and has comparable safety and efficacy to YF-Vax.  See the MMWR Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017 for further information for providers regarding yellow fever vaccine.

ACIP Meetings